ABOS vs AVGO · $73.3M cap vs P/E 87, rev $41.50B
Acumen Pharmaceuticals Inc (ABOS) versus Broadcom Inc (AVGO) — a side-by-side from cached financials, not a winner call.
Acumen Pharmaceuticals Inc (ABOS) is a biotechnology company listed on US.
Broadcom Inc (AVGO) is a semiconductors company listed on US. It is led by Hock Tan.
ABOS does not have a complete income-statement cache yet.
Latest reported AVGO revenue for 2026-05-03 was $41.50B. Net income was $16.66B. AVGO currently screens at market cap $2.12T and trailing P/E 86.9.
ABOS currently screens at market cap $73.3M. AVGO currently screens at market cap $2.12T and trailing P/E 86.9.
Not investment advice. Open the ABOS and AVGO stock pages for the full models.
Not investment advice.